Wuhan General Group (China) IncOver The Counter Market:WUHN
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Wuhan General Group (China) Inc | 60.0 | 0.0x | --- |
Cannabis Bioscience International Holdings Inc | 6.3M | 0.0x | --- |
Fortress Biotech Inc | 33.1M | -0.2x | --- |
Personalis Inc | 64.0M | -0.6x | --- |
Sorrento Therapeutics Inc | 11.0M | 0.0x | --- |
MDxHealth SA | 67.4M | 0.0x | --- |
Company Information
Wuhan General Group (China) Inc is a South Africa-based bioceutical company. The Company is focused on alternative plant-based cannabinoids and mental health therapeutic research. Through its subsidiary, Neur.ai, the Company is engaged in developing a portfolio of receptor agonists based on neurotransformational medicine for the treatment of mental illness. The Company develops and commercializes a range of cannabidiol (CBD) and mushrooms-based products under the Dr. AnnaRx, Medspresso, and Liviana brands. The brands span across a range of premium CBD- and mushroom-infused consumer goods, including bioceuticals, health and wellness, and precision foods and beverages. In addition, the Company's research and clinical trials with psilocybin are aimed at new therapies that seek to help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Its Liviana brand offers CBD-infused raw honey and CBD-infused extra virgin olive oils.
Contact Information
- Headquarters
- Unit 1 Masons Press, 7 Ravenscraig Road,CAPE TOWN, South Africa 7925
- Phone
- 514-928-7368
- Fax
- ---
Executives
- Chief Executive Officer
- Jeffrey Robinson
- Director of Human Resources and Communications
- Luka Marjanovic
- Director of Corporate Strategic Partnerships
- Selah Abrams
- Director of Social Media
- Rameez Adair
- Chief Innovation Officer
- Riyad Domingo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $60.00 |
|---|---|
Revenue (TTM) | $80.4M |
Shares Outstanding | 55.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.88 |
EPS | $-0.34 |
Book Value | $3.30 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
